Boston Celtics remain favorites for the NBA Eastern Conference title, despite trailing behind the Cleveland Cavaliers. Ben and Donnie break down the odds.

Plus, a look at the teams crashing the bubble, the players who fans love to hate and transfers who have upgraded their new programs.

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

CEO Michael Mahoney highlighted the company’s exceptional performance in 2024, with operational sales growth of 23% in Q4 and 18.5% for the full year. Organic sales grew 20% in Q4, exceeding guidance.

New England's likely starting 11 played more than 70 minutes on Saturday, as the Revolution wrapped the MLS portion of their ...

Jayson Tatum scored 40 points and the Boston Celtics easily handled the New York Knicks for the second time this season,<a ...

Your sweetheart might have expected a red dish set with hearts, an umbrella with a heart border or even a heart-shaped pillow ...

The MBTA announced South Coast Rail passenger service will start March 24, connecting New Bedford and Fall River to Boston ...

Reports Q4 revenue $4.56B, consensus $4.42B. “2024 was one of the best years in the history of Boston Scientific (BSX), fueled by our innovative portfolio, the launch of our FARAPULSE Pulsed ...

The Republican president made waves at the final prayer breakfast during his first term, which came after his first ...

Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.561 billion during the fourth quarter of 2024 ...

Kara Dunn scored 15 points, Zoesha Smith made the winning free throws in the final seconds and No. 17 Georgia Tech ended the game on a 12-3 run and beat SMU 70-69.